
    
      A 7-Month Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300mg/day
      of Extended-release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal
      Depressive Episodes in Subjects with a History of Seasonal Affective Disorder Followed by an
      8-week Observational Follow-up Phase
    
  